POET Technologies: A $50 Million Lumilens Deal and a $400M Cash Haul Amid a Legal Storm and CFO Exit

The photonics firm POET Technologies has secured a $50 million order from Lumilens for electro-optical interposer engines, with potential to swell to $500 million over five years, even as it wrestles with a class-action lawsuit, the departure of its long-serving finance chief, and a make-or-break shareholder vote later this month. The stock, which lost nearly half its value in a single day earlier this year, is trying to stabilise as the company navigates its most critical period to date.

First deliveries to Lumilens are expected in the second half of 2026 – a slight delay of a few weeks from the original schedule. The deal adds heft to a production ramp that calls for more than 30,000 optical engine modules this year, with samples of new 800G and 1.6T transceivers due before year-end and mass production slated for 2027.

Capital cushion and operational build-out

POET’s financial position got a major boost in May when it closed a $400 million capital raising, issuing 19 million shares along with an equal number of warrants. The cash pile now stands at over $400 million, giving the company a liquidity ratio above 35 and minimal debt. Proceeds are earmarked for manufacturing capacity, research, acquisitions, and the light-source business, with a goal of wafer fabrication and optical engine assembly capacity growing tenfold.

First-quarter revenue climbed to $503,389 from $166,760 a year earlier, though the net loss widened to $12.3 million, or $0.08 per share. Cumulative retained losses total $291 million, and the company disclosed a material weakness in internal controls.

Should investors sell immediately? Or is it worth buying POET Technologies?

Legal escalation after Celestial cancellation

The legal troubles began after the client Celestial AI abruptly cancelled all orders, triggering a 47% one-day crash that wiped $7.15 from the stock price. The trigger was an interview in which chief financial officer Thomas Mika was alleged to have violated a confidentiality agreement. That, together with claims that POET erroneously described its tax status – it should have been classified as a passive foreign investment company (PFIC) – has landed the company in the crosshairs of US securities litigation.

Bronstein, Gewirtz & Grossman announced another class action on June 7, covering investors who bought shares between April 1 and April 27, 2026. Two other firms, Bragar Eagel & Squire and The Gross Law Firm, had already launched similar suits. The class actions name Mika and CEO Venkatesan among the defendants. The deadline for lead plaintiffs to come forward is June 29.

To sidestep the PFIC issue going forward, POET’s board has approved a plan to redomicile from Canada to Delaware. Shareholders will vote on that proposal at the annual meeting on June 26. If approved, US investors would no longer face the punitive tax treatment of PFIC status. The company has also committed to publishing annual PFIC information statements if the designation threatens to reapply. Whether the move affects the pending lawsuits remains uncertain, since the claims focus on past communications rather than future corporate structure.

Governance shake-up

Amid the legal turmoil, Mika has announced his resignation as CFO after a decade in the role, though he will step down sometime during the year. The board has begun searching for a successor. The timing is delicate, as Mika is a named defendant in the class action, and the lead plaintiff deadline falls just three days after the shareholder vote.

In a parallel move, POET hired Dr. Sandeep Kumar, a veteran of 18 years at Silicon Labs as senior vice president for worldwide operations, as its new chief operating officer. His mandate is to prepare production in Malaysia for high-volume output.

POET Technologies at a turning point? This analysis reveals what investors need to know now.

Two dates, one verdict

June 26 and June 29 sit only a weekend apart. The first decides whether POET can shed its PFIC label; the second will determine who leads the legal charge against the company. On Monday, the stock traded at €11.06, up 5.5% from Friday’s close but still more than 40% off its 52-week high of €18.84. The market is weighing a growth story backed by a $400 million war chest and a potentially lucrative Lumilens relationship against a litigation risk that could take months or years to resolve.

The next two weeks will show whether POET can put its legal crisis behind it and focus on the factory floor – or whether the courtroom will continue to dictate the share price.

Ad

POET Technologies Stock: New Analysis - 8 June

Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated POET Technologies analysis...

en | CA73044W3021 | POET | boerse | 69502341 |